Development of a nanodrug-delivery system camouflaged by erythrocyte membranes for the chemo/phototherapy of cancer

Nanomedicine (Lond). 2020 Mar;15(7):691-709. doi: 10.2217/nnm-2019-0454. Epub 2020 Feb 11.

Abstract

Aim: Development of a new drug-delivery system using a compound derived from Pronephrium penangianum (J5) for the treatment of cervical cancer. Materials & methods: The delivery system was developed using Prussian blue nanoparticles, camouflaged by red blood cell membrane and with folic acid surface modifications. Results: Our results showed the successful development of a nanodrug-delivery system, which increases the half-life and immune evasion ability of the drug. The mechanism of this system was through suppressing B-cell lymphoma 2 and increasing B-cell lymphoma 2-associated X protein and the cleaved caspase level. An in vivo study also confirmed good antitumor activity without any side effects to normal tissue. Conclusion: This drug-delivery system provides a good alternative for the treatment of cervical cancer using J5.

Keywords: RBC membrane; chemo/photothermal therapy; drug delivery; natural compound.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Delivery Systems*
  • Erythrocyte Membrane*
  • Folic Acid
  • Hyperthermia, Induced
  • Mice
  • Mice, Nude
  • Nanoparticles*
  • Neoplasms* / therapy
  • Phototherapy*

Substances

  • Folic Acid